It's a Small, Small World

Citrics Biomedical is making strides in the biomedical field with its innovative bone substitute, the CitrOSponge, which recently won $30,000 at a nanotech competition. This new synthetic material is designed to not only aid in bone repair but also naturally break down in the body as real bone regenerates. With a team that includes Notre Dame alumni and a biomedical engineering expert, Citrics is positioned at the intersection of business and cutting-edge nanotechnology.

Published

Related News & Stories

EMBA Advisory Board 2026 Group Shot.

Alumni Community

Notre Dame EMBA launches advisory board

A new board of alumni will bring an outside perspective to the Executive MBA program. [Pictured from left: Brandon Erlacher, Aarron Hale, Art Betancourt, Andrew Nemeth, Tyler Tigges, John A. Lundy, Sarah Mills, Mary Dow, George A. Arce Jr., Jim Rosenberg and Cassie Kline. Not pictured: Ruth Idzik, Sam Scala and John Turner.]

All News & Stories